Aprea Therapeutics, Inc. (APRE)
EBITDA Margin
-10103.30%
TTM · Period ending:
APRE EBITDA Margin
Latest reported-10103.30%period ending
Latest reported-10103.30%period ending
APRE EBITDA Margin (0.00% → -10103.30%)
Annual ebitda margin
High-resolution chart · PNG
APRE ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 0% | |
| -860.9448% | |
| -2,448.3795% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |